And let's remember that we will have NO COMPETITOR in this space - IHL has embarked on a strategy to come up with formulations to address markets for which there is no other treatment available.
Does that mean that if we can then capture even just 20% of the addressable market (very conservative), we'll be worth 4x more than Resmed?? Simplistic way of looking at it but you get the idea
IHL Price at posting:
6.1¢ Sentiment: Buy Disclosure: Held